Altamira Therapeutics Ltd.
CYTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8 | -$4 | -$27 | -$17 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$0 | -$0 | $0 |
| Stock-Based Comp. | $1 | $0 | $0 | $1 |
| Change in WC | $0 | -$4 | $4 | $1 |
| Other Non-Cash | $2 | -$3 | $14 | $2 |
| Operating Cash Flow | -$6 | -$12 | -$9 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$2 | -$3 |
| Net Acquisitions | $0 | $1 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | $0 | $0 | -$0 |
| Investing Cash Flow | -$0 | $1 | -$2 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $1 | $6 | -$0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | $10 | $4 | $7 |
| Financing Cash Flow | $7 | $11 | $10 | $7 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | $1 | -$1 | -$10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $0 | $1 | $11 |
| End Cash | $1 | $1 | $0 | $1 |
| Free Cash Flow | -$6 | -$12 | -$11 | -$17 |